Progenics Pharmaceuticals (PGNX) 8-K Other Events

Exhibit 99.1

Consolidated Statements of Comprehensive Income (Loss)

(amounts in thousands)

	For the Years Ended December 31,
	2011		2010			2009
Net income (loss)	$	10,381	($	69,725	)	($	30,612	)
Other comprehensive income:
Net change in unrealized loss on auction rate and marketable securities		24		15			990
Total other comprehensive income		24		15			990
Comprehensive income (loss)	$	10,405	($	69,710	)	($	29,622	)